Vaginal Challenge with an SIV-Based Dual Reporter System Reveals That Infection Can Occur throughout the Upper and Lower Female Reproductive Tract

PLoS Pathogens

Volumn 10, Issue 10, 2014, Pages

  Stieh, Daniel J ^a   Maric, Danijela ^a   Kelley, Z L ^a   Anderson, Meegan R ^a   Hattaway, Holly Z ^a   Beilfuss, Beth A ^a   Rothwangl, Katharina B ^a   Veazey, Ronald S ^b   Hope, Thomas J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD68 ANTIGEN; GENOMIC DNA; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE TRANSMISSION; FEMALE; FEMALE GENITAL SYSTEM; GENE; GENE EXPRESSION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOHISTOCHEMISTRY; INFECTION; LUCIFERASE ASSAY; LYMPH NODE; NESTED POLYMERASE CHAIN REACTION; NONHUMAN; POLYMERASE CHAIN REACTION; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; VAGINA; VIRUS ENTRY; ANIMAL; CELL LINE; MUCOSA; RAT; UTERINE CERVIX; VIROLOGY;

SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALS; CELL LINE; CERVIX UTERI; FEMALE; HIV INFECTIONS; LYMPH NODES; MACACA MULATTA; MUCOUS MEMBRANE; RATS; SIMIAN IMMUNODEFICIENCY VIRUS; VAGINA;

EID: 84908316043     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004440     Document Type: Article

References (45)

1. Joint United Nations Programme on HIV/AIDS. (2010) Global report: UNAIDS report on the global AIDS epidemic. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS. pp. v.
2. Haynes BF, McElrath MJ, (2013) Progress in HIV-1 vaccine development. Curr Opin HIV AIDS 8: 326–332.
3. Shattock RJ, Moore JP, (2003) Inhibiting sexual transmission of HIV-1 infection. Nat Rev Microbiol 1: 25–34.
4. Haase AT, (2011) Early events in sexual transmission of HIV and SIV and opportunities for interventions. Annu Rev Med 62: 127–139.
5. Keele BF, Estes JD, (2011) Barriers to mucosal transmission of immunodeficiency viruses. Blood 118: 839–846.
6. Stone M, Keele BF, Ma ZM, Bailes E, Dutra J, et al. (2010) A limited number of simian immunodeficiency virus (SIV) env variants are transmitted to rhesus macaques vaginally inoculated with SIVmac251. J Virol 84: 7083–7095.
7. Miller CJ, Li Q, Abel K, Kim EY, Ma ZM, et al. (2005) Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. J Virol 79: 9217–9227.
8. Li Q, Estes JD, Schlievert PM, Duan L, Brosnahan AJ, et al. (2009) Glycerol monolaurate prevents mucosal SIV transmission. Nature 458: 1034–1038.
9. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, et al. (2010) Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men. New England Journal of Medicine 363: 2587–2599.
10. Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, et al. (2010) Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 329: 1168–1174.
11. J Marrazzo GR, Nair G, et al. (2013) Pre-exposure prophylaxis for HIV in women: daily oral tenofovir, oral tenofovir/emtricitabine or vaginal tenofovir gel in the VOICE study (MTN 003). Conference on Retroviruses and Opportunistic Infections Goergia World Congress Centre, Atlanta.
12. Friend DR, Kiser PF, (2013) Assessment of topical microbicides to prevent HIV-1 transmission: Concepts, testing, lessons learned. Antiviral Research 99: 391–400.
13. Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, et al. (2012) Preexposure Prophylaxis for HIV Infection among African Women. N Engl J Med
14. Negre D, Mangeot PE, Duisit G, Blanchard S, Vidalain PO, et al. (2000) Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells. Gene Ther 7: 1613–1623.
15. Shaner NC, Campbell RE, Steinbach PA, Giepmans BN, Palmer AE, et al. (2004) Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat Biotechnol 22: 1567–1572.
16. Rabinovich BA, Ye Y, Etto T, Chen JQ, Levitsky HI, et al. (2008) Visualizing fewer than 10 mouse T cells with an enhanced firefly luciferase in immunocompetent mouse models of cancer. Proc Natl Acad Sci U S A 105: 14342–14346.
17. Koyanagi Y, Miles S, Mitsuyasu RT, Merrill JE, Vinters HV, et al. (1987) Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 236: 819–822.
18. Cronin J, Zhang XY, Reiser J, (2005) Altering the tropism of lentiviral vectors through pseudotyping. Curr Gene Ther 5: 387–398.
19. Zufferey R, Donello JE, Trono D, Hope TJ, (1999) Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol 73: 2886–2892.
20. Donello JE, Loeb JE, Hope TJ, (1998) Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element. J Virol 72: 5085–5092.
21. Durand S, Cimarelli A, (2011) The inside out of lentiviral vectors. Viruses 3: 132–159.
22. Marx PA, Spira AI, Gettie A, Dailey PJ, Veazey RS, et al. (1996) Progesterone implants enhance SIV vaginal transmission and early virus load. Nat Med 2: 1084–1089.
23. Lee B, Sharron M, Montaner LJ, Weissman D, Doms RW, (1999) Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc Natl Acad Sci U S A 96: 5215–5220.
24. Poonia B, Walter L, Dufour J, Harrison R, Marx PA, et al. (2006) Cyclic changes in the vaginal epithelium of normal rhesus macaques. J Endocrinol 190: 829–835.
25. Milush JM, Kosub D, Marthas M, Schmidt K, Scott F, et al. (2004) Rapid dissemination of SIV following oral inoculation. AIDS 18: 2371–2380.
26. Zhang Z, Schuler T, Zupancic M, Wietgrefe S, Staskus KA, et al. (1999) Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science 286: 1353–1357.
27. Miller CJ, Shattock RJ, (2003) Target cells in vaginal HIV transmission. Microbes Infect 5: 59–67.
28. Spira AI, Marx PA, Patterson BK, Mahoney J, Koup RA, et al. (1996) Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J Exp Med 183: 215–225.
29. Hladik F, Sakchalathorn P, Ballweber L, Lentz G, Fialkow M, et al. (2007) Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity 26: 257–270.
30. Pandrea I, Parrish NF, Raehtz K, Gaufin T, Barbian HJ, et al. (2012) Mucosal simian immunodeficiency virus transmission in African green monkeys: susceptibility to infection is proportional to target cell availability at mucosal sites. J Virol 86: 4158–4168.
31. Wira CR, Fahey JV, (2008) A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle. AIDS 22: 1909–1917.
32. Cramer DW, Welch WR, Berkowitz RS, Godleski JJ, (2007) Presence of talc in pelvic lymph nodes of a woman with ovarian cancer and long-term genital exposure to cosmetic talc. Obstetrics and gynecology 110: 498–501.
33. Rosenblatt KA, Weiss NS, Cushing-Haugen KL, Wicklund KG, Rossing MA, (2011) Genital powder exposure and the risk of epithelial ovarian cancer. Cancer Causes Control 22: 737–742.
34. Cook LS, Kamb ML, Weiss NS, (1997) Perineal powder exposure and the risk of ovarian cancer. Am J Epidemiol 145: 459–465.
35. Blumenkrantz MJ, Gallagher N, Bashore RA, Tenckhoff H, (1981) Retrograde menstruation in women undergoing chronic peritoneal dialysis. Obstetrics and gynecology 57: 667–670.
36. Halme J, Hammond MG, Hulka JF, Raj SG, Talbert LM, (1984) Retrograde menstruation in healthy women and in patients with endometriosis. Obstetrics and gynecology 64: 151–154.
37. Masurier C, Salomon B, Guettari N, Pioche C, Lachapelle F, et al. (1998) Dendritic cells route human immunodeficiency virus to lymph nodes after vaginal or intravenous administration to mice. J Virol 72: 7822–7829.
38. Ghanem KG, Shah N, Klein RS, Mayer KH, Sobel JD, et al. (2005) Influence of sex hormones, HIV status, and concomitant sexually transmitted infection on cervicovaginal inflammation. J Infect Dis 191: 358–366.
39. Rotchford K, Strum AW, Wilkinson D, (2000) Effect of coinfection with STDs and of STD treatment on HIV shedding in genital-tract secretions: systematic review and data synthesis. Sex Transm Dis 27: 243–248.
40. Vishwanathan SA, Guenthner PC, Lin CY, Dobard C, Sharma S, et al. (2011) High susceptibility to repeated, low-dose, vaginal SHIV exposure late in the luteal phase of the menstrual cycle of pigtail macaques. J Acquir Immune Defic Syndr 57: 261–264.
41. Kersh EN, Henning T, Vishwanathan SA, Morris M, Butler K, et al. (2014) SHIV susceptibility changes during the menstrual cycle of pigtail macaques. J Med Primatol [epub ahead of print].
42. Akiyama M, Okabe H, Takakura K, Fujiyama Y, Noda Y, (1999) Expression of macrophage inflammatory protein-1alpha (MIP-1alpha) in human endometrium throughout the menstrual cycle. Br J Obstet Gynaecol 106: 725–730.
43. Kallikourdis M, Andersen KG, Welch KA, Betz AG, (2007) Alloantigen-enhanced accumulation of CCR5+ ‘effector’ regulatory T cells in the gravid uterus. Proc Natl Acad Sci U S A 104: 594–599.
44. Padian NS, van der Straten A, Ramjee G, Chipato T, de Bruyn G, et al. (2007) Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet 370: 251–261.
45. Wei X, Decker JM, Liu H, Zhang Z, Arani RB, et al. (2002) Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother 46: 1896–1905.